RxDoctor Payments Data

Kimberly Matzie, MD

Colon & Rectal Surgery · Fairfax, VANPI 1861579898

Payments from drug & device makers

What this record shows

This record is dominated by education: $24,004 of the $27,924 with a category attached, or 86.0%. Intuitive Surgical accounts for 97.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $13,403 and has fallen 99.6% since, to $49 in 2025. Among colon & rectal surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,924in general payments, 2019–2025

Across 52 payments — averaging $537.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$27K
  • Johnson & Johnson$227
  • Myriad Genetic Laboratories, Inc.$130
  • Covidien LP$117
  • Integra Lifesciences Corporation$49
  • Medtronic$41
  • plus $125 from 6 others

What the payments were for

  • Travel & lodging$9343%
  • Food & beverage$2,95611%
  • Education$24,00486%
  • Gifts$280%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,924 in reported general payments places this provider in the 95th percentile of 46 colon & rectal surgery providers in Virginia.

See all colon & rectal surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$192,840
Medicare patients
394
Services billed
787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metronidazole11$227
Ondansetron OdtOndansetron13$83
Neomycin Sulfate12$59
Oxycodone Hcl11$40

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →